Waldenström's Macroglobulinemia Treatment

Current Therapeutic Options in Waldenström Macroglobulinemia

Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia.

Waldenström macroglobulinemia: diagnosis and treatment

Abstract. Waldenström macroglobulinemia (WM), according to the 2017 World Health Organization classification, is defined as the co-occurrence of ...

The Lymphoma Channel: Waldenström's Macroglobulinemia

Explore the latest advances, such as rituximab and proteasome inhibitor-based therapies that have demonstrated efficacy in symptom management, and targeted ...

Waldenström Macroglobulinemia - Leukemia & Lymphoma Society

The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib (Imbruvica®) may also be effective in treating patients with WM and BNS (see page 7). Supportive Therapy ...

Combining the Drugs Venetoclax and Rituximab as a First ... - SWOG

Waldenström's macroglobulinemia (WM) is a rare type of lymphoma. It is also called lymphoplasmacytic lymphoma.

Imbruvica (Ibrutinib): First Drug Approved for the Treatment of ...

Waldenström's macroglobulinemia (WM), also known as lymphoplasmacytic lymphoma, is an indolent subtype of B-cell non-Hodgkin lymphoma.1,2 WM is ...

What are the current treatment options for Waldenström's ...

Over the past few years, more and more treatment options have been identified, including monoclonal antibodies and targeted therapies, such as ...

Waldenstrom's Macroglobulinemia Prognosis: What Is the Survival ...

This form of non-Hodgkin lymphoma often can't be cured, but treatments can help keep symptoms under control. Many people live for years or ...

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's ...

We conclude that the addition of ibrutinib to rituximab represents a viable treatment approach for patients with Waldenström's macroglobulinemia ...

Exciting updates in Waldenström's macroglobulinemia - YouTube

2022 IWMF Ed Forum-Everything You Want to Know About BTK Inhibitors, Do's and Don'ts · 2024 IWMF Ed Forum - Pick Your Poison Treatment Options.

BeiGene Highlights Waldenström's Macroglobulinemia Innovation at ...

Mobasher said. “Our BTK inhibitor BRUKINSA has become a standard of care for these patients and as shown through our long-term follow-up data at IWWM, continues ...

Transformed Waldenström Macroglobulinemia: Update on ... - MDPI

The most common initial treatment used is a chemo-immunotherapy (CIT), such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). The ...

Waldenström's macroglobulinemia - a review - SciELO

For the treatment of symptomatic patients, alkylating agents, purine analogs and anti-CD20 monoclonal antibodies are used. However, the disease is incurable and ...

Diagnosis and Management of Waldenstrom's Macroglobulinemia

Now, when we think about BTK Inhibitors is a very different way of treating patients with Waldenstrom's because patients take a few pills every day and that's ...

Jack Whelan: Surviving Waldenström Macroglobulinemia Thanks to ...

In fact, as a result of such advances, the U.S. Food and Drug Administration (FDA) is currently reviewing a new targeted drug for the treatment of Waldenström, ...

Treatment and outcome patterns of patients with Waldenström's ...

Waldenström macroglobulinemia (WM) is an uncommon indolent B-cell non-Hodgkin lymphoma characterized by the accumulation of lymphoplasmacytic ...

Treatment of Waldenstrom's Macroglobulinemia - SpringerLink

Combination therapy either with nucleoside analogues with alkylating agents and/or rituximab or rituximab with chemotherapy such as CHOP or ...

Story of Hope: Lu, Waldenström Macroglobulinemia Survivor

Six years since my last treatment (read story below), I am grateful beyond words to take a pill every morning, which has given me one of my best treatment ...

Waldenstrom Macroglobulinemia: Who Gets What and When?

As many as 50% of people at the time of their Waldenstrom macroglobulinemia (WM) diagnosis won't need drug therapy for a number of years.

Diagnosis and treatment of Waldenstrom's macroglobulinemia in a ...

Waldenstrom's macroglobulinemia (WM) is a rare neoplastic disease with bone marrow involvement and overproduction of immunoglobulin M (IgM).